Press "Enter" to skip to content

FDA warns about rare instances of liver injury, failure with HCV therapies – Healio

admin 0

FDA warns about rare instances of liver injury, failure with HCV therapies  Healio

The FDA has received reports that the use of Mavyret, Zepatier or Vosevi to treat chronic hepatitis C in patients with moderate to severe liver disease has …

“liver cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *